CO6230979A2 - Uso de quitosanas para incrementar el indice de crecimiento de las uñas - Google Patents

Uso de quitosanas para incrementar el indice de crecimiento de las uñas

Info

Publication number
CO6230979A2
CO6230979A2 CO09098720A CO09098720A CO6230979A2 CO 6230979 A2 CO6230979 A2 CO 6230979A2 CO 09098720 A CO09098720 A CO 09098720A CO 09098720 A CO09098720 A CO 09098720A CO 6230979 A2 CO6230979 A2 CO 6230979A2
Authority
CO
Colombia
Prior art keywords
chitosan
nail
water
derivative
acceptable salt
Prior art date
Application number
CO09098720A
Other languages
English (en)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6230979(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of CO6230979A2 publication Critical patent/CO6230979A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

1.- Quitosana, un derivado de quitosana soluble en agua y/o su sal fisiológicamente aceptable para la aceleración del índice de crecimiento de la uña.2.- Un derivado de quitosana soluble en agua de acuerdo con la reivindicación 1, que es un aminopolisacárido quitosana.3.- Un amino-polisacárido quitosana de acuerdo con la reivindicación 2, caracterizado por tener un peso molecular mayor que 50000 Da.4.- Un amino-polisacárido quitosana de acuerdo con la reivindicación 2, caracterizado por tener un peso molecular de 100000 a 500000 Da.5.- Un amino-polisacárido quitosana de acuerdo con la reivindicación 2, que es un quitosana hidroxialquilo.6.- Un quitosana hidroxialquilo de acuerdo con la reivindicación 5, que es quitosana hidroxipropilo.7.- Un amino-polisacárido quitosana de acuerdo con la reivindicación 2, que es quitosana carboxialquilo.8.- Quitosana, un derivado de quitosana soluble en agua y/o su sal fisiológicamente aceptable de acuerdo con cualquiera de las reivindicaciones precedentes, que se administra en combinación con uno o más principios activos.9.- Quitosana, un derivado de quitosana soluble en agua y/o su sal fisiológicamente aceptable de acuerdo con cualquiera de las reivindicaciones precedentes, en donde dicho principio activo es para el tratamiento de enfermedades de la uña.10.- Quitosana, un derivado de quitosana soluble en agua y/o su sal fisiológicamente aceptable de acuerdo con la reivindicación 9, en donde dicha enfermedad de la uña se selecciona de infección de la uña, soriasis de la uña, lichen planus de la uña, dermatitis atópica de la uña,distrofia de la uña, avulsión de la uña.11.- Quitosana, un derivado de quitosana soluble en agua y/o su sal fisiológicamente aceptable de acuerdo con la reivindicación 9, en donde dicho principio activo se selecciona de corticosteroides, agentes antisoriáticos, agentes inmunosupresores, agentes antimicóticos, agentesantisépticos. humectantes, y/o agentes fortalecedores de la uña.12.- Quitosana, un derivado de quitosana soluble en agua y/o su sal fisiológicamente aceptable de acuerdo con cualquiera de las reivindicaciones precedentes, que se administra tópicamente.
CO09098720A 2007-02-14 2009-09-14 Uso de quitosanas para incrementar el indice de crecimiento de las uñas CO6230979A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07102335A EP1958638A1 (en) 2007-02-14 2007-02-14 Use of chitosans to increase nail growth rate

Publications (1)

Publication Number Publication Date
CO6230979A2 true CO6230979A2 (es) 2010-12-20

Family

ID=38345983

Family Applications (1)

Application Number Title Priority Date Filing Date
CO09098720A CO6230979A2 (es) 2007-02-14 2009-09-14 Uso de quitosanas para incrementar el indice de crecimiento de las uñas

Country Status (32)

Country Link
US (3) US8680074B2 (es)
EP (3) EP1958638A1 (es)
JP (3) JP5426401B2 (es)
KR (2) KR101131015B1 (es)
CN (2) CN102988405A (es)
AR (1) AR065316A1 (es)
AT (1) ATE522221T1 (es)
AU (1) AU2008214693B2 (es)
BR (1) BRPI0807595A2 (es)
CA (1) CA2677715C (es)
CL (2) CL2008000444A1 (es)
CO (1) CO6230979A2 (es)
CY (2) CY1112058T1 (es)
DK (2) DK2377541T3 (es)
EA (2) EA201270116A1 (es)
ES (2) ES2436647T3 (es)
HK (1) HK1133189A1 (es)
HR (2) HRP20110667T1 (es)
IL (1) IL200269A (es)
MA (1) MA31236B1 (es)
ME (1) ME00830B (es)
MX (1) MX2009008686A (es)
MY (2) MY163297A (es)
NZ (1) NZ578896A (es)
PH (1) PH12014500274A1 (es)
PL (2) PL2377541T3 (es)
PT (2) PT2377541E (es)
RS (2) RS53143B (es)
SI (2) SI2377541T1 (es)
UA (1) UA100011C2 (es)
WO (1) WO2008098869A2 (es)
ZA (1) ZA200905443B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
WO2010109423A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
EP2763649A2 (en) * 2011-10-05 2014-08-13 Allergan, Inc. Compositions for enhancing nail health
PT2793946T (pt) * 2011-12-20 2019-05-08 Urgo Rech Innovation Et Developpement Composição tópica filmogénica e uso da mesma para tratar ou prevenir a onicofagia
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (en) * 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropyl chitosan for the treatment of onychomycosis
EP2910245A1 (en) * 2014-02-21 2015-08-26 Polichem SA Topical antifungal composition for treating onychomycosis
CN109893472A (zh) * 2019-04-09 2019-06-18 涿州皓原箔业有限公司 一种环保无毒水性卸甲液及其制备方法
ES2834732B2 (es) * 2019-12-17 2022-03-24 Univ Valladolid Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento
CN111388416B (zh) * 2020-02-26 2022-03-08 浙江康德药业集团股份有限公司 一种盐酸利多卡因胶浆剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541305A1 (de) * 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
EP0615745B1 (en) 1993-02-19 1997-05-02 Howard Green Compositions containing corneocyte proteins
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
RU2108114C1 (ru) * 1996-12-27 1998-04-10 Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. Биологическая композиция для лечения ран "коллахит"
ITTO980264A1 (it) 1998-03-26 1999-09-26 Silvio Rossi Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
ATE411032T1 (de) * 2001-12-14 2008-10-15 Dnp Canada Inc Verwendungen von chitosanoligosacchariden
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
JP3881992B2 (ja) 2004-07-30 2007-02-14 シャープ株式会社 受信装置、受信プログラム、および受信プログラムを記録した記録媒体
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
HRP20131175T1 (hr) 2014-01-17
SI2117564T1 (sl) 2011-12-30
EA018390B1 (ru) 2013-07-30
AU2008214693A2 (en) 2009-09-10
KR101131015B1 (ko) 2012-03-29
PL2117564T3 (pl) 2012-03-30
CN102988405A (zh) 2013-03-27
ES2369116T3 (es) 2011-11-25
UA100011C2 (ru) 2012-11-12
US8680074B2 (en) 2014-03-25
ZA200905443B (en) 2010-10-27
JP2013213048A (ja) 2013-10-17
EA201270116A1 (ru) 2012-06-29
SI2377541T1 (sl) 2014-01-31
RS53143B (en) 2014-06-30
JP6045663B2 (ja) 2016-12-14
PH12014500274A1 (en) 2016-06-06
CL2013002052A1 (es) 2014-02-21
CA2677715A1 (en) 2008-08-21
HRP20110667T1 (hr) 2011-10-31
BRPI0807595A2 (pt) 2014-07-22
RS52031B (en) 2012-04-30
US20160015620A1 (en) 2016-01-21
KR101323762B1 (ko) 2013-11-01
ME00830B (me) 2012-03-20
EP2117564B1 (en) 2011-08-31
EP2117564A2 (en) 2009-11-18
MA31236B1 (fr) 2010-03-01
MX2009008686A (es) 2009-08-21
EP2377541A1 (en) 2011-10-19
JP2015221823A (ja) 2015-12-10
JP2010518138A (ja) 2010-05-27
CN101663039B (zh) 2013-08-07
PT2117564E (pt) 2011-10-17
EP1958638A1 (en) 2008-08-20
CL2008000444A1 (es) 2008-08-22
MY154499A (en) 2015-06-30
CA2677715C (en) 2014-10-14
KR20090121312A (ko) 2009-11-25
JP5426401B2 (ja) 2014-02-26
WO2008098869A3 (en) 2008-10-09
KR20110075043A (ko) 2011-07-05
NZ578896A (en) 2012-02-24
DK2377541T3 (da) 2013-11-11
US20140147401A1 (en) 2014-05-29
MY163297A (en) 2017-09-15
IL200269A0 (en) 2010-04-29
CY1115136T1 (el) 2016-12-14
ATE522221T1 (de) 2011-09-15
US20100152133A1 (en) 2010-06-17
IL200269A (en) 2015-10-29
EA200901093A1 (ru) 2010-02-26
AU2008214693A1 (en) 2008-08-21
US9173827B2 (en) 2015-11-03
DK2117564T3 (da) 2011-10-17
PL2377541T3 (pl) 2014-04-30
HK1133189A1 (en) 2010-03-19
CY1112058T1 (el) 2015-11-04
ES2436647T3 (es) 2014-01-03
CN101663039A (zh) 2010-03-03
WO2008098869A2 (en) 2008-08-21
AR065316A1 (es) 2009-05-27
AU2008214693B2 (en) 2013-05-02
EP2377541B1 (en) 2013-10-23
PT2377541E (pt) 2013-11-21

Similar Documents

Publication Publication Date Title
CO6230979A2 (es) Uso de quitosanas para incrementar el indice de crecimiento de las uñas
DE602006004451D1 (de) Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
JP2014505733A5 (es)
CR10838A (es) Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
CN105055642A (zh) 一种复方胍类消毒剂及其制备方法
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
BRPI0509863A (pt) liberação de fármaco para fundo de olho
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
BR112017026287A2 (pt) composições de hidroxipropil beta-ciclodextrina e métodos
NO20025999D0 (no) Klart, vandig anestetisk preparat
UY32503A (es) Formulación pesticida de uso agrícola a base de avermectina y un agente fotoprotector
AR070025A1 (es) Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
JP2010518138A5 (es)
RS51578B (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN
AR033666A1 (es) Compuestos polipeptidicos, los procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, el uso de los mismos para la fabricacion de medicamentos y envases comerciales y articulos de fabricacion que comprenden dichos compuestos y dichas composiciones farmaceuticas
EA200701525A1 (ru) Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением
MD3619G2 (ro) Remediu medicamentos nazal cu acţiune anticongestivă
WO2008084533A1 (ja) メニエール病治療薬
HK1135694A1 (en) Imino-imidazo-pyridine derivatives having antithrombotic activity
MD2975F1 (en) Remedy in the form of gel for rosacea treatment
MD3250G2 (ro) Metodă de tratament al sindromului cheroto-conjunctivitei sica
JO2440B1 (en) Formulation of oral pharmaceutical polymers for controlled release of terbutalate sulfate.
AR058509A1 (es) Compuesto macrolona de eritromicina, su uso para preparar un medicamento y composicion farmaceutica que lo comprende
RU2007122549A (ru) Способ профилактики гнойных осложнений при панкреонекрозе

Legal Events

Date Code Title Description
FG Application granted